Literature DB >> 1974351

Lymphocyte subsets and HLA-DR expression in normal pancreas and chronic pancreatitis.

P Bedossa1, J Bacci, G Lemaigre, E Martin.   

Abstract

In an attempt to study the mechanisms leading to fibrosis in chronic pancreatitis, an in situ immunohistochemical investigation of lymphocytes and of class II major histocompatibility complex expression (HLA-DR) by epithelial cells has been designed. Samples of normal pancreas (n = 8), chronic calcifying pancreatitis (n = 4), chronic obstructive pancreatitis (n = 6), and diffuse fibrosing pancreatitis (n = 6) have been studied. In normal pancreas, T-lymphocytes were rare and were located in the epithelial layer of pancreatic ducts and in the periductal connective tissue. Duct cells were constantly HLA-DR negative. In chronic calcifying pancreatitis and chronic obstructive pancreatitis, T cells were numerous and were located around ducts and in the spreading areas of fibrous septa. In chronic obstructive pancreatitis, the duct cells strongly expressed the HLA-DR antigen. In diffuse fibrosing pancreatitis, fibrous tissue was devoid of lymphocytes and duct cells never expressed the HLA class II antigen. These results suggest that lymphocytes are involved in the fibrosing process occurring in chronic calcifying pancreatitis and chronic obstructive pancreatitis but not in diffuse fibrosing pancreatitis. The significance of de novo expression of HLA-DR antigen by duct cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974351     DOI: 10.1097/00006676-199007000-00007

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  15 in total

1.  Effector T lymphocyte subsets in human pancreatic cancer: detection of CD8+CD18+ cells and CD8+CD103+ cells by multi-epitope imaging.

Authors:  K Ademmer; M Ebert; F Müller-Ostermeyer; H Friess; M W Büchler; W Schubert; P Malfertheiner
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

2.  Loss of TGF-beta signaling contributes to autoimmune pancreatitis.

Authors:  K B Hahm; Y H Im; C Lee; W T Parks; Y J Bang; J E Green; S J Kim
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  Non-alcoholic duct destructive chronic pancreatitis.

Authors:  N Ectors; B Maillet; R Aerts; K Geboes; A Donner; F Borchard; P Lankisch; M Stolte; J Lüttges; B Kremer; G Klöppel
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

4.  Secretory immunoglobulin A in pancreatic juice and pancreatic tissue of patients with chronic pancreatitis.

Authors:  J Emmrich; M Seyfarth; P Conradi; F Plath; G Sparmann; M Löhr; S Liebe
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

5.  Cytokine mRNA levels and lymphocyte infiltration in pancreatic tissue during experimental chronic pancreatitis induced by dibutyltin dichloride.

Authors:  G Sparmann; S Behrend; J Merkord; H D Kleine; E Graser; T Ritter; S Liebe; J Emmrich
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

6.  Comparative immunocytochemical study of MHC class II expression in human donor pancreas and isolated islets.

Authors:  W Lu; D G Pipeleers; G Klöppel; L Bouwens
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

7.  Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism.

Authors:  H Kanno; M Nose; J Itoh; Y Taniguchi; M Kyogoku
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

8.  A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid.

Authors:  W-M Qu; T Miyazaki; M Terada; K Okada; S Mori; H Kanno; M Nose
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

9.  Specific cellular immune responses to pancreatic antigen in chronic pancreatitis and Sjögren's syndrome.

Authors:  I Nishimori; K Okazaki; Y Yamamoto; M Morita; S Tamura; Y Yamamoto
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

10.  Serum levels of interleukin-1 beta and interleukin-6 in patients with chronic pancreatitis.

Authors:  T Bamba; U Yoshioka; H Inoue; Y Iwasaki; S Hosoda
Journal:  J Gastroenterol       Date:  1994-06       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.